Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Longeveron LLC, a leading developer of adult stem cell technologies for aging-related and life-threatening conditions, announced today that it has...
Longeveron LLC, a leading developer of adult stem cell technologies for chronic, aging-related and life-threatening conditions, announced today that...
Longeveron LLC, a biopharmaceutical company that develops cellular therapies for aging-related diseases, will discuss the company's latest clinical...
Longeveron LLC, a biopharmaceutical company that develops cellular therapies for aging-related diseases, will play a prominent role when leading...
Longeveron LLC, a biopharmaceutical company that develops cell therapies for aging-related diseases, announced that Joshua M. Hare, M.D., will be a...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has been awarded ...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies, announced that Co-Founder and Chief Science Officer Joshua Hare, M.D....
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company will present at...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has appointed...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the International Conference ...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that Dr. Joshua Hare, Chief...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for age-related diseases, announced that it is currently recruiting for ...
Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related conditions, announced that it has received a $750,000 ...
Longeveron announced that its pioneering clinical trial to treat infants with Hypoplastic Left Heart Syndrome officially started with the first...
The early results of mesenchymal stem cells studies look encouraging for lessening or reversing the effects of Aging Frailty, Joshua M. Hare, M.D.,...
Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge...
Longeveron LLC, a leading life sciences company developing innovative therapies for age-related diseases, announced that the company is progressing...
Longeveron LLC, a regenerative medicine company developing cellular therapies, announced today that it treated its first patient in the Company's...
Longeveron LLC is sponsoring a regenerative medicine symposium at the 2017 International Association of Gerontology and Geriatrics (IAGG) World...
Longeveron LLC, a leading regenerative medicine company developing innovative therapies for age-related diseases, announced the publication of Phase...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.